Institutions / Mak Capital One LLC

Mak Capital One LLC

CIK 1385702 · Institution · as of Mar 31, 2026
Portfolio value
$604.32M
Positions
21
As of
Mar 31, 2026

Portfolio trend

Portfolio value

$604.32M-18.7%
$743.15M$673.74M$604.32MQ4 '25Q1 '26

Positions

21+0.0%
212121Q4 '25Q1 '26

Top holdings

Mar 31, 2026
CompanyClassValueShares% of portfolio
Champion Homes Inc$95.37M1,282,37415.8%
Agilysys Inc$84.85M1,192,73014.0%
Grupo Financiero Galicia SAGGALADR$66.75M1,429,07511.0%
Acadia Healthcare Company, Inc.$56.91M2,432,9629.4%
Autolus Therapeutics plcAUTLADR$46.40M33,621,4877.7%
Grupo Supervielle S.A.SUPVADR$40.08M4,250,0006.6%
Coursera, Inc.$32.70M5,618,7495.4%
Annexon, Inc.$26.17M4,724,0434.3%
Standard Biotools Inc.$24.06M26,172,6264.0%
Comstock Inc.$17.58M5,763,7292.9%
ClearPoint Neuro, Inc.$17.30M1,901,4892.9%
Udemy, Inc.$16.90M3,658,5202.8%
Cenovus Energy Inc$14.24M536,8322.4%
Honest Company, Inc.$14.04M4,776,0882.3%
Yatra Online Inc$13.51M12,170,3012.2%
Cryoport, Inc.$11.78M1,423,2652.0%
Perma Fix Environmental Services Inc$9.82M918,6731.6%
Protalix BioTherapeutics, Inc.$7.69M3,544,1391.3%
Uniqure NV$7.21M441,2051.2%
Fiverr International Ltd$806.4K80,4790.1%
Sangamo Therapeutics, Inc.$138.6K561,5380.0%

Activity

InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.
DateActionCompanyValueShares ΔPosition afterImpact
Q1 2026
as of
ExitQualcomm INC/DE$-67.40M-394K
-100.00%
high
Q1 2026
as of
NewAcadia Healthcare Company, Inc.$56.91M+2.4M
2,432,962
9.42% of portfolio
high
Q1 2026
as of
TrimChampion Homes Inc$-53.37M-718K
-35.88%
1,282,374
15.78% of portfolio
high
Q1 2026
as of
NewComstock Inc.$17.58M+5.8M
5,763,729
2.91% of portfolio
medium
Q1 2026
as of
NewClearPoint Neuro, Inc.$17.30M+1.9M
1,901,489
2.86% of portfolio
medium
Q1 2026
as of
AddCoursera, Inc.$10.87M+1.9M
+49.78%
5,618,749
5.41% of portfolio
medium
Q1 2026
as of
AddAnnexon, Inc.$9.78M+1.8M
+59.68%
4,724,043
4.33% of portfolio
medium
Q1 2026
as of
ExitTalkspace, Inc$-8.04M-2.2M
-100.00%
medium
Q1 2026
as of
ExitDay One Biopharmaceuticals, Inc.$-7.70M-826K
-100.00%
medium
Q1 2026
as of
NewProtalix BioTherapeutics, Inc.$7.69M+3.5M
3,544,139
1.27% of portfolio
medium